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Abstract
Background: Breast cancer is reported as one of the most common cancers among females worldwide. Infectious
agents especially viruses have been considered as role players in the development of breast cancer. Although some
investigations suggest an association between bovine leukemia virus (BLV) and breast cancer, the involvement of
this virus as a risk factor remains controversial. The present study aimed to find out any possible association
between BLV and breast cancer through conducting a systematic review and meta-analysis.
Methods: Systematic literature search was performed by finding related case-control articles from the PubMed,
Google Scholar, Web of Science, Scopus, and EMBASE databases. The heterogeneity and the multivariable-adjusted
OR and corresponding 95% CI were applied by meta-analysis and forest plot across studies. All statistical analyses
were performed using Stata 14.1.
Result: Based on a comprehensive literature search, 9 case-control studies were included for meta-analysis. The
combination of all included studies showed that BLV infection is associated with an increased risk of breast cancer
[summary OR (95% CI) 2.57 (1.45, 4.56)].
Conclusion: This is the first meta-analysis to analyze a potential association between BLV infection and the risk of
breast cancer. Control of the infection in cattle herds and screening of the milk and dairy products may help to
reduce the transmission of the virus to humans.
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Introduction
Breast cancer is known as the second common cancer
(after skin cancers) in females in the United States [1, 2].
According to the World Health Organization estimates,
about 2.1 million women are diagnosed with breast
cancer annually [3]. According to the data from cancer
statistics, 2019, approximately 268,600 cases are
diagnosed each year in the United States. This is about
30% of all new cases of diagnosed cancers in women.
Moreover, breast cancer is considered as the second
deadliest cancer (after lung cancer) in female population
with annual 627,000 deaths in the world [3] and 41,760
deaths in the United States. This represents 15% of all
cancer deaths in women [1]. Total incidence rate of
cancer in women has been constant over the last de-
cades, but an increase in the incidence of breast cancer
has been reported from 2006 to 2015 [1]. Due to the
high incidence and mortality rates of breast cancer, it is
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important to find new risk factors that might be associ-
ated with the stimulation and development of breast
cancer. Evidently, breast cancer is a multifactorial
disease and a large number of risk factors could play
important roles in the development of the disease [3].
Currently, the main cause of breast cancer is not known,
however, genetics, malnutrition, lifestyle, aging, tobacco
and alcohol use, obesity, and infectious agents are
considered as risk factors [4]. Based on the International
Agency for Research on Cancer, infectious agents, such
as viruses are associated with the development and
progression of 15–20% of tumors, in general [5].
Among viruses, Human papillomavirus [6] and Mouse
Mammary Tumor Virus-Like Virus (MMTV-LV) [7]
infections have been associated with the development of
human breast cancer. Another study showed that
Epstein-Barr virus (EBV) infection may have a potential
role in the breast cancer development, as well [3].
Moreover, several recent studies have suggested a
possible relationship between BLV (Bovine leukemia
virus) and breast cancer [8, 9].
BLV belongs to the Retroviridae family. The virus is
further classified in Orthoretrovirinae subfamily, and
deltaretrovirus genus which is considered as a possible
zoonotic infection [9]. The main hosts for BLV is cattle
but it can infect other animal species such as water buf-
falo, sheep, alpaca, rabbits, rats, pigs, and goats, as well.
The prevalence of BLV infection is high in cattle herds
and varies from about 39 to 100% in beef and dairy
herds, respectively. Although BLV can easily transmit
through infected blood and milk, it causes disease in
less than 5% of infected cattle [8, 9]. BLV is associated
with chronic lymphatic leukemia and the infection of
mammary cells might be associated with breast tumor
in the hosts. The BLV tax protein has some regulatory
functions (transcription activator) and could be associ-
ated with transformation through inhibition of DNA re-
pair system and disruption of tumor suppressor genes
[10]. The mechanism of BLV transmission to humans is
not known, however, raw milk consumption can trans-
mit the virus from cattle to human population [11].
The study by Buehring et al. showed that the genome
and antibodies against the capsid protein (P24) of BLV
can be found in female blood samples [8, 9]. Buehring
et al. detected the BLV DNA in the breast tissue of 80%
of women with breast cancer in compare with 41% of
negative control group [12].
Because there are some discrepancies regarding the as-
sociation between BLV and breast cancer, the associ-
ation of this virus as a risk factor for breast cancer
development remains controversial. The present study
aimed to find out any possible association between BLV




This study was done based on the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) guidelines. Systematic literature search was
conducted by independent reviewers and all related
articles from global databases were collected from
January 1995 to January 2020 [13]. All case-control
studies that investigated the BLV infection in breast
cancers were collected from well-known databases
such as the PubMed, Google Scholar, Web of Science,
Scopus, and EMBASE. The Mesh-indexed keywords,
including “breast cancer”, “Bovine Leukemia virus”
OR “BLV” and their synonyms were used. Additional
related articles were assessed by reviewing the refer-
ences of the selected publications and reviews as well
as the excluded ones.
Study selection
All the articles were imported into Endnotes software
version X7and the duplicates were removed. Then, the
title and abstract of the articles were analyzed to exclude
all irrelevant publications. Full-texts of the remaining
articles were reviewed and disagreements between the
reviewers were resolved. All remaining articles were in-
cluded. All those responsible for searching and filtering
the articles were contacted by email and other Virtual
Contact Methods.
Eligibility criteria
The following criteria were applied for the selection of
qualified studies in this research:
All BLV case-control and prevalence studies published
in English language, publication date between 1995 to
January 2020, availability of the full-text, and application
of standard assays for the detection of BLV nucleic acid
and antigens, including RT-PCR, Immunohistochemistry
(IHC), In situ hybridization (ISH), ELISA (enzyme-linked
immunosorbent assay) Nested PCR and In situ PCR
assays.
The exclusion criteria were as follows:
Studies published in languages other than English,
studies regarding breast cancer association with other
viruses rather than BLV, studies examining the preva-
lence of BLV infection in male patients, article types of
systematic review, meta-analysis, case report, letter to
the editor, and conference abstracts.
Data extraction
Data extraction for the selected studies carried out by
two independent reviewers. The extracted data included:
the author’s name, year of publication, country, geo-
graphical area, type of study, sample type, target gene,
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the sample size, number of BLV positive samples, mean
age, and detection method.
Quality assessment
After selection of the relevant studies in terms of the
title and contents, the Newcastle- Ottawa assessment
scale (NOS) was used to evaluate the quality of the
articles. The NOS is used to evaluate three quality
parameters of selection, Comparability, and Exposure.
Each step has some questions and the score is assessed
based on the given stars (*). These questions are related
to the case definition, case and control selection, defin-
ition of control, comparability of case and control, detec-
tion method and the type of control (1 star for each
question). In prepared checklist, the highest score was
10 and the lowest acceptable score was 6. Finally, the
articles with a score of at least 6 were selected and data
was extracted (Table 1).
Statistical analysis
The heterogeneity of study populations was assessed by
random-effects meta-analysis framework and for visual
inspection of the multivariable-adjusted OR and corre-
sponding 95% CI a forest plot was produced across stud-
ies. The logarithm of the odds ratio and its associated
standard error was used in this meta-analysis. Der-
Simonian and Laird method was also used to estimate
pooled OR with its corresponding 95% CI [20]. The
Cochran’s Q statistic (P < 0.10) was applied to check the
heterogeneity between studies [21] and quantified using
the I2 statistic [22]. The I2 > 50% was considered as high
heterogeneity. Sources of heterogeneity were identified
using meta-regression and subgroup analyses. A com-
bination of the visual inspection of funnel plots [23],
Begg’s test and Egger’s test [24] were performed to in-
vestigate the presence and the effect of publication bias.
The extent of inferences dependency on a particular
study or group of studies was detected using the sensi-
tivity analysis. Two-tailed statistics and the significance
level of less than 0.05 were considered for all analyses,
except the heterogeneity test with significance level of
less than 0.1. All statistical analyses were performed
using Stata 14.1 (Stata Corp, College Station, TX, USA).
Result
Study selection
The PRISMA flow chart was used to illustrate the results
of the literature search and selection process (Fig. 1).
Altogether, 13,631 potentially relevant articles were
initially selected. Duplicates and irrelevant studies were
removed. Of 70 remained articles, 61 studies were ex-
cluded for following reasons: did not present sufficient
data, studies without control group, and studies that
were not in English. Finally, 9 articles were included in
the meta-analysis.
Study characteristics
The characteristics of the selected studies of this analysis
are summarized in Table 1. Nine case-control studies
were selected for further analysis of which 3 were from
the North (US) and Caribbean America, 2 studies from
Western pacific region (Australia), 2 studies from
Eastern Mediterranean region (Iran), and 2 studies from
south America (1 study from Brazil and the other from
Colombia Formalin-fixed paraffin-embedded (FFPE)
tissue samples were investigated in all the studies and
blood samples were analyzed in 2 studies as well. Meth-
odologically, in-situ PCR, nested-PCR, and conventional
PCR tests were performed in 8, 3, and 1 studies, respect-
ively. Virus detection was performed based on the detec-
tion of viral gag gene in 2 studies and viral tax gene was
investigated in the rest.
Characteristics of participant
In total, there were 826 cases and 898 individuals as
control group. The median age in case and control
groups was ranged between 46.4–56.1 and 36.4–54.4, re-
spectively. The sample size in case and control groups
was ranged between 22 and 172 and 17–200, respect-
ively. Publication date of the articles ranged from 1995
to 2020.
Risk of breast cancer in association with BLV
Based on Cochran’s Q and I2 statistics, significant
heterogeneity was found between the selected studies
(Q = 46.62, df = 8, P < 0.001, I2 = 84.8%) and supported
the use of a random effects model. To study heterogen-
eity sources, meta-regressions were carried out based on
the sample type, the detection target, the detection
method and the sample size. The results are presented
in Table 2. In addition, a subgroup meta-analysis was
performed by detection-target. The results of each study
and the total summary results for the nine selected case-
control studies of the BLV infection and breast cancer,
according to detection-target are shown in Fig. 2.
Overall analysis of the used target gene for BLV detection
Analysis of the 9 case-control studies revealed that BLV
infection was associated with an increased risk of breast
cancer [summary OR (95% CI) 2.57 (1.45, 4.56)]. Of the
9 studies, detection of BLV infection was performed via
identification of the tax gene in 2 studies, while the gag
gene was the target in the other 7 studies (Table 3).
Based on the gag gene, there were 225 cases and 253 in-
dividuals as the control group. Based on the tax gene,
there were 601 cases and 645 individuals as the control
group. A sensitivity analysis was performed by successive
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removal of individual studies at a time to evaluate the
effect of each study on pooled results. A significant
positive association [range of summary ORs 2.26–3.02]
was consistently found between BLV virus and breast
cancer which did not alter the pooled results. This
indicates that the meta-analysis performed in this study
was powerful.
Discussion
The main etiology of breast cancer is unknown and
several factors are associated with cancer development
and progression. Previous studies have reported that
infectious agents especially viruses could be related to
breast cancer development [3]. In some meta-analysis
studies of the association of papillomavirus, EBV, and
MMV with breast cancer, the results showed that
epidemiologically, the prevalence of these viral infections
in patients with breast cancer was higher in comparison
with the control group [3, 6, 25]. Several cross-sectional
and case-control studies indicated that BLV virus
infection may be associated with breast cancer, as well
[12, 18].
To the best of our knowledge, this study is the first
meta-analysis investigating the association between BLV
and breast cancer. In this study, 9 case-control articles
investigating the association between BLV infection in
patients with breast cancer and the control group were
examined on blood samples and FFPE tissue samples.
Present study showed that the prevalence of BLV
infection, based on the studies that used In-situ PCR,
Nested PCR and conventional PCR tests, was higher in
patients with breast cancer in comparison with controls.
Fig. 1 PRISMA flowchart of included studies
Table 2 The result of meta-regressions
Variables Coefficient Standard error T p value Lower 95% Upper 95%
Sample type 0.07 1.38 0.05 0.96 −3.78 3.92
Detection target −1.35 0.68 −1.98 0.11 −3.24 0.54
Detection method 0.23 0.66 0.35 0.74 −1.61 2.07
Sample size 0.004 0.005 −0.79 0.47 −0.02 0.01
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Overall, the 9 case-control studies showed that BLV
infection was associated with an increased risk of breast
cancer [summary OR (95% CI) 2.57 (1.45, 4.56)] and this
indicates that the infection with BLV may be a risk
factor for breast cancer. Although no association was
reported in two studies that used BLV gag gene as the
target for PCR amplification, this might be due to either
small sample size or high frequency of mutations in this
gene. In fact, deletion of the Gag, Pol, and Env segments
of the genome has been reported in advanced stages of
leukemia’s and lymphomas to more likely provide the
virus with the ability to escape host’s immune responses.
This may lead to lower detection levels of BLV infection
in assays that target these regions of the genome [9, 26].
In order to evaluate the publication bias, assuming that
small studies may be more susceptible to publication
bias in comparison to larger studies, a visual inspection
of the funnel plot and statistical tests were applied. The
results presented in Fig. 3 revealed no publication bias
for the association between the BLV and risk of breast
cancer (data not shown; P = 0.297, for Begg’s adjusted
rank correlation test and P = 0.237 for Egger’s regression
asymmetry test). Moreover, the trim-and-fill method was
unable to find any missing study.
Fig. 2 Association between BLV and breast cancer risk in case-control studies based on detection-target
Table 3 Association between breast cancer and BLV detection-target gene
Gene target No of studies Odds ratio (95%Cl) Heterogeneity chi squared Odds ratio two-tailed p value Heterogeneity test, p value
Gag 2 0.84 (0.49–1.44) 0.56 0.51 0.45
Tax 7 3.54 (1.92–6.52) 31.64 < 0.001 < 0.001
total 9 2.57 (1.92–6.52) 46.62 0.001 < 0.001
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Recent studies have shown that BLV receptors exist
on different cell types and the virus can enter different
tissues. The tax gene in BLV is responsible for oncogenic
activity and inhibits the mechanism of cell excision re-
pair system and leads to oxidative damage in the cell.
This may be associated with various cancer types such
as lung and breast cancers. Olaya-Galan et al. showed
that BLV-contaminated milk can transmit the virus hori-
zontally to other hosts [27]. On the other hand, milk
and dairy products are one of the most important
sources of human nutrition, and the raw consumption of
these products can be involved in virus transmission to
humans [11].
Language barriers, limitation to female-based studies,
and excluding the studies without a control group were
the important limitations of this study.
Conclusion
This is the first meta-analytic study to find the associ-
ation between BLV infection and the risk of breast
cancer. Control of the infection in cattle herds and
screening of the milk and dairy products may help to
reduce the transmission of the virus to humans.
However, more research are needed to have a better un-
derstanding regarding the involvement of this virus in
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